Telehealth clinical trial cuts hospital cardiac readmissions by 76%

Israel-based SHL Telemedicine has announced that a UK clinical study of its SmartHeart system aimed at monitoring patients recovering from acute coronary syndrome (ACS) saw a 76% drop in hospital readmissions.

The study, carried out by Imperial College London and dubbed TELE-ACS, also saw a 41% drop in the likelihood of patients monitored by the technology vising an emergency department and decreases in patient-reported symptoms, including chest pain, breathlessness, and dizziness.